Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1445224A details a novel Ru-catalyzed asymmetric transfer hydrogenation process for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Advanced acylation method for high-purity cefpirome sulfate. Cost-effective industrial process ensuring stable supply for global pharmaceutical manufacturers.
Novel synthetic route for Trenbolone Acetate reduces cost and waste. Reliable pharmaceutical intermediate supplier offering scalable production.
Patent CN1812990A details a novel Pd/C catalyzed route for famciclovir, achieving superior purity by minimizing hydrolysis impurities through optimized solvent systems.
Patent CN111606923B details a cost-effective 3-step synthesis of racemic clopidogrel using methyl benzoylformate, offering significant supply chain advantages.
Patent CN1293039C reveals a superior method for [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative synthesis, offering enhanced yield and purity for ephedrine production.
Advanced synthesis of Quetiapine Hemifumarate via novel thiosalicylic acid route. High yield, eco-friendly process for cost-effective API manufacturing.
Patent CN1100410A details a novel route for (+)-2-(3,4-dichlorophenyl)-4-hydroxybutylamine using N-methylglucamine resolution and borane reduction for high-purity tachykinin antagonists.
Novel synthetic route for Quetiapine Hemifumarate using o-bromonitrobenzene. Reduces toxicity and improves yield for API manufacturing.
Advanced synthetic route for Quetiapine Hemifumarate using o-bromonitrobenzene. Offers mild conditions, high purity, and cost reduction in API manufacturing.
Patent CN1219756C details a novel Suzuki coupling method using formate additives to suppress dimer impurities, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel quinoline kinase inhibitor synthesis offers high yield and purity for pharmaceutical intermediates, ensuring cost reduction and supply chain reliability.
Patent CN1530171A discloses a robust heterogeneous catalyst system for producing high-ee hydroxy esters, enabling significant cost reduction in chiral synthesis manufacturing.
Novel 7-ACA silanization method improves yield and purity significantly. Reduces sewage and drying time for pharmaceutical intermediates manufacturing processes effectively.
Patent CN101979393B details a novel silylation route for cephalothin acid offering high purity and reduced environmental impact for pharmaceutical supply chains.
Patent CN1538950A details a mild transfer hydrogenation method for amine synthesis using Ru/Rh catalysts, offering cost reduction in API manufacturing and high optical purity.
Patent CN104673733B reveals a novel HHDH enzyme route for high-purity statin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced synthesis of 3-dehydroshikimic esters via IBX oxidation. A scalable, high-yield route for pharmaceutical intermediates offering significant cost and supply chain advantages.
Patent CN106316825A reveals a scalable chemical route for trans-4-hydroxycyclohexanecarboxylic acid. This method offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.